Table 1.

QRT-PCR analysis of cell cycle related genes in response to drug treatment.

		10
		6-h incubation			12-h incubation			24-h incubation
GeneName	RefSeqID	10 M	20 M	30 M	10 M	20 M	30 M	10 M	20 M	30 M
TNFα; tumor necrosis factor alpha	NM_000594	−1.02	−1.08	−1.23	1.51	−3.90	−8.41	1.72	−1.87	−4.00
GADD45alpha	NM_001924	1.59	1.04	1.24	1.16	1.28	1.72	1.14	5.19	3.65
TXNRD1; thioredoxin reductase 1	NM_003330	1.24	−1.73	−1.11	−1.40	−1.39	−1.42	1.78	1.90	1.28
SKP2; S-phase kinase-assoc. prot. 2	NM_005983	1.87	−1.55	−1.43	−1.06	−1.53	2.11	−4.58	−7.60	−8.04
APC4; anaphase-promoting complex 4	NM_013367	1.31	1.25	1.22	1.27	1.45	1.03	−2.45	−2.16	−2.23
CCND1; cyclin D1	NM_053056	−1.42	1.05	−1.04	1.25	1.57	−1.30	−1.43	−2.14	−4.36
CCNE2; cyclin E2	NM_057749	1.04	−1.12	1.09	1.24	1.23	−1.08	1.23	1.13	−1.23
CDKN2B; cyclin-dependent kinase inhib. 2B	NM_078487	−1.22	−1.26	1.27	1.05	−1.50	1.02	−2.74	−7.11	−9.36
		16
		6-h incubation			12-h incubation			24-h incubation
GeneName	RefSeqID	10 M	20 M	30 M	10 M	20 M	30 M	10 M	20 M	30 M
TNFα; tumor necrosis factor alpha	NM_000594	1.56	-1.76	−1.69	−1.13	−1.72	−1.75	−2.23	1.16	1.45
GADD45alpha	NM_001924	−1.02	1.12	1.27	1.67	1.38	−1.07	1.78	1.86	2.63
TXNRD1; thioredoxin reductase 1	NM_003330	1.01	1.14	1.01	1.68	−1.18	1.37	2.42	2.01	2.60
SKP2; S-phase kinase-assoc. prot. 2	NM_005983	1.03	−1.08	1.67	1.74	1.34	2.10	−1.40	−1.87	−1.30
APC4; anaphase-promoting complex 4	NM_013367	−1.10	1.26	1.43	1.75	1.08	1.11	−1.28	−1.90	−1.43
CCND1; cyclin D1	NM_053056	1.15	1.11	1.63	1.07	1.22	1.09	−1.60	−1.01	−1.19
CCNE2; cyclin E2	NM_057749	1.09	1.30	1.48	1.94	1.44	1.83	−1.33	−2.62	−2.33
CDKN2B; cyclin-dependent kinase inhib. 2B	NM_078487	1.69	1.18	2.27	-1.61	1.96	1.88	−6.22	−7.86	−14.83